EGFR antibody (Extracellular, Ligand Binding Domain)
Quick Overview for EGFR antibody (Extracellular, Ligand Binding Domain) (ABIN110080)
Target
See all EGFR AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- Extracellular, Ligand Binding Domain
-
Specificity
- Human EGF-Receptor (extracellular ligand binding site) There were no cross reactivities obtained with v-erb-B
-
Purification
- Prepared from rabbit serum by affinity purification using a column to which the fusion protein immunogen was coupled.
-
Immunogen
- Human EGF-Receptor
-
Isotype
- IgG1
-
-
-
-
Application Notes
- ELISA, Immunohistochemistry (paraffin sections, 1.7 ng/ml PBS 1% BSA) Flow cytometry. This antibody has not been tested for use in all applications. This does not necessarily exclude its use for non-tested procedures. The stated dilutions are recommendations only. We suggest that the applicant titrates the antibody in his/her system using appropriate negative/positive controls.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Resuspend in aqua bidest.
-
Storage
- 4 °C
-
-
- EGFR (Epidermal Growth Factor Receptor (EGFR))
-
Alternative Name
- Epidermal Growth Factor-Receptor
-
Background
- Cell culture supernatant, Protein G purified, PBS pH 7,4, 0,1% NaN3
-
Gene ID
- 1956
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Stem Cell Maintenance, Hepatitis C, Positive Regulation of Response to DNA Damage Stimulus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation, S100 Proteins
Target
-